cremophor el has been researched along with lactic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allémann, E; Benrezzak, O; Boyle, RW; Brasseur, N; Gurny, R; Kudrevich, SV; Leroux, JC; Rousseau, J; Van Lier, JE | 1 |
Allémann, E; Brasseur, N; Kudrevich, SV; Lewis, K; Rousseau, J; van Lier, JE | 1 |
Feng, SS; Win, KY | 1 |
Chang, DH; Kim, BO; Kim, SO; Lee, SW; Seo, MH; Shim, MS | 1 |
Danhier, F; Feron, O; Jérôme, C; Lecouturier, N; Marchand-Brynaert, J; Préat, V; Vroman, B | 1 |
5 other study(ies) available for cremophor el and lactic acid
Article | Year |
---|---|
PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.
Topics: Animals; Colloids; Delayed-Action Preparations; Emulsions; Glycerol; Indoles; Injections, Intravenous; Lactates; Lactic Acid; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Photochemotherapy; Polyesters; Polyethylene Glycols; Polymers; Radiation-Sensitizing Agents; Solvents; Tissue Distribution | 1995 |
Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles.
Topics: Animals; Biodegradation, Environmental; Coloring Agents; Drug Carriers; Emulsions; Glycerol; Indoles; Lactates; Lactic Acid; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Microspheres; Neoplasm Transplantation; Organometallic Compounds; Particle Size; Photochemotherapy; Polyesters; Polyethylene Glycols; Polymers; Radiation-Sensitizing Agents; Solubility; Suspensions; Thigh; Tumor Cells, Cultured | 1996 |
In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation.
Topics: Antineoplastic Agents, Phytogenic; Area Under Curve; Drug Carriers; Drug Delivery Systems; Emulsifying Agents; Glycerol; Humans; Lactic Acid; Nanostructures; Paclitaxel; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface-Active Agents; Vitamin E | 2006 |
Ionically fixed polymeric nanoparticles as a novel drug carrier.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Calcium Chloride; Drug Carriers; Drug Stability; Glycerol; Injections, Intravenous; Lactic Acid; Molecular Weight; Nanoparticles; Paclitaxel; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Rats; Rats, Sprague-Dawley; Spectrophotometry; Static Electricity | 2007 |
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Drug Carriers; Drug Evaluation, Preclinical; Ethylene Oxide; Excipients; Flow Cytometry; Glycerol; HeLa Cells; Humans; Lactic Acid; Lactones; Male; Mice; Mice, Inbred Strains; Nanoparticles; Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface-Active Agents; Survival Analysis | 2009 |